1)Hepatic stimulator substance肝细胞刺激因子
1.Protection of hepatic stimulator substance against chemotherapeutic liver damage induced by cyclophosphamide in mice inoculated with S_(180) cells;人肝细胞刺激因子对环磷酰胺致S_(180)荷瘤小鼠肝损伤的保护作用
2.ObjectiveTo establish two fatty liver models of rats: high-fatty diet induced nonalcoholic fatty liver (NAFL), high-fatty diet and alcohol induced compound fatty liver(CFL), to investigate their possible mechanism, and to study the effect of hepatic stimulator substance(HSS) on the two fatty liver models and their possible mechanism after the models were made.制造模型成功后再用肝细胞刺激因子(HSS)进行治疗,观察其疗效并探讨其作用机理。
3.ObjectiveTo study the therapy effect and possible mechanism of hepatic stimulator substance (HSS) associated Runganling on nonalcoholic fatty liver disease (NAFLD) of rat.目的研究肝细胞刺激因子(hepatic stimulator substance,HSS)联合润肝灵方剂对大鼠非酒精性脂肪肝(nonalcoholic fatty liver disease,NAFLD)的治疗作用及可能机制。
英文短句/例句
1.The Co-effect of Hepatic Stimulator Substance in Combination with Adriamycin on the Cellular Apoptosis of Human Liver Cancer in Nude Mice肝细胞刺激因子与阿霉素协同诱导肝癌细胞凋亡的动物试验研究
2.Hepatic Stimulator Substance Protects Against Chemotherapeutic Liver Damage in Mice;肝细胞刺激因子治疗小鼠化疗性肝损伤的实验研究
3.Experimental Studies of Hepatic Stimulator Substance Associated Runganling in Treating Nonalcoholic Fatty Liver Disease on Rat Model;肝细胞刺激因子联合润肝灵方剂治疗大鼠非酒精性脂肪肝的实验研究
4.Establishment of Nonalcoholic and Compound Fatty Liver Models of Rats and Observation of the Effects of Hepatic Stimulator Substance;非酒精性和混合性大鼠脂肪肝模型的建立及肝细胞刺激因子治疗效果观察
5.Induction of Cytokine on Hepatocytes by Cytokine Inducer PPD, PolyI: C and PHA;干扰素诱生剂刺激肝细胞产生细胞因子研究
6.lymphocytosis stimulating factor淋巴细胞增多刺激因子
7.granulocyte colony stimulating factor粒细胞集落刺激因子
8.Effects of bone marrow stem cell mobilization with Granulocyte colony-stimulating factor for the therapy of liver damage in rats粒细胞集落刺激因子骨髓干细胞动员治疗大鼠肝损伤的实验研究
9.Human Granulocyte Macrophage Colony Stimulating Factor[重组]人粒细胞巨噬细胞集落刺激因子
10.The Study of Differentially Expressed Genes Stimulated by Transforming Growth Factor β1 in Hepatic Stellate Cells;转化生长因子β1刺激肝星状细胞差异表达基因研究
11.Increased cellular proliferation in BEL-7402 hepatoma cells transfected by human hepatic stimulator substance gene转人肝刺激物质基因的肝癌细胞增殖状态研究
12.Experimental Research of G-CSF Therapeutic Effect on Acute Hepatic Failure;粒细胞集落刺激因子治疗急性肝衰竭的实验研究
13.Effects of Danshensu on TGFB1 Stimulating Hepatic Stellate Cell Signaling Transduction;丹参素对转化生长因子β1刺激肝星状细胞信号传导的影响
14.The Study on Relationship between Int Erllukin-8 and Liver Injury of Rats Causing by Endotoxicemia and Interverntion of Recombinant Granulocyte-Colony Stimulating Factor重组粒细胞集落刺激因子对内毒素血症肝功能障碍的干预研究
15.Effects of IFN-α on the Expressions of Smad3 and Smad7 in the Hepatic Stellate Cell Excited by TGF-β_1干扰素-α对转化生长因子-β_1刺激肝星状细胞表达Smad3及Smad7的影响
16.Expression of cytokines mRNA induced by B7 gene Jurkat cells by cytarabine阿糖胞苷刺激Jurkat细胞B7和细胞因子mRNA表达
17.Investigation of Interactions between Heparin-like Sulfated Polysaccharides and Proteins at Both Molecular and Cellular Level;肝素等硫酸多糖与粒细胞集落刺激因子等蛋白质在分子和细胞水平上的相互作用研究
18.Humen Granulocyte Colony Stimulating Factor[重组]人粒细胞集落刺激因子
相关短句/例句
B lymphocyte stimulatorsB细胞刺激因子
1.Measurement and clinical significance of B lymphocyte stimulators level in peripheral blood plasma from patients with B cell malignancies;B细胞恶性肿瘤患者外周血浆B细胞刺激因子水平测定及临床意义
2.B lymphocyte stimulators(Blys)is a new member of tumor necrosis factor superfamily,which produces a marked effect through specific binding with three receptors.B细胞刺激因子(Blys)是肿瘤坏死因子(TNF)超家族的新成员,通过与B细胞表面三个受体特异性结合而发挥作用。
3)B lymphocyte stimulatorB细胞刺激因子
1.Role of recombinate human B lymphocyte stimulator on peripheral B cells in systemic lupus erythematosus patients;人重组B细胞刺激因子对系统性红斑狼疮外周血B细胞功能的影响
2.Expression of B lymphocyte stimulator in peripheral blood mononuclear cells in individuals with systemic lupus erythematosus and the role of interferon-γ on it s expression;IFN-γ对系统性红斑狼疮患者外周血单个核细胞B细胞刺激因子表达的调控
3.AIM: To clone and express soluble B lymphocyte stimulator (sBLyS).目的:钓取人B细胞刺激因子基因,构建其表达的大肠杆菌工程菌,并体外表达、纯化可溶性B细胞刺激因子方法:从人外周血单个核细胞(PBMC)中提取总RNA并逆转录得到cDNA,用PCR扩增目的基因,连接到原核生物表达载体pET-30a上。
4)P-cell stimulating factorP-细胞刺激因子
5)hepatic stimulator substance肝刺激因子
1.Objective To assay the effect of hepatic stimulator substance (HSS) on the expression of EGFR/DNA of human hepatoma cells.目的检测肝刺激因子 (HSS)对人肝癌细胞EGFR/DNA表达的影响。
6)GM-CSF粒巨细胞集落刺激因子
1.Clinical research about prevention from oral ulcer induced by chemotherapy by granulomacrocytic colony stimulating factors(GM-CSF);粒巨细胞集落刺激因子预防化疗后口腔溃疡的研究
延伸阅读
正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂
